Cenobamate suppresses seizures without inducing cell death in neonatal rats
Epilepsy & Behavior · 2024
DOI: 10.1016/j.yebeh.2024.109898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Eric Witherspoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Physiology, Georgetown University, Washington, DC, USA. Hauptthemen laut MEDLINE: Animals, Newborn, Seizures, Anticonvulsants, Rats, Sprague-Dawley. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, NICHD.
Abstract (Originalsprache)
GABA modulators such as phenobarbital (PB) and sodium channel blockers such as phenytoin (PHT) have long been the mainstay of pharmacotherapy for the epilepsies. In the context of neonatal seizures, both PB and PHT display incomplete clinical efficacy. Moreover, in animal models, neonatal exposure to these medications result in neurodegeneration raising concerns about safety. Cenobamate, a more recently approved medication, displays unique pharmacology as it is both a positive allosteric modulator of GABA-A receptors, and a voltage-gated sodium channel blocker. While cenobamate is approved for adult use, its efficacy and safety profile against neonatal seizures is poorly understood. To address this gap, we assessed the efficacy and safety of cenobamate in immature rodents. Postnatal day (P)7 rat pups were pretreated with cenobamate and challenged with the chemoconvulsant pentylenetetrazole (PTZ) to screen for anti-seizure effects. In a separate experiment, P7 rats were treated with cenobamate, and brains were processed to assess induction of cell death. Cenobamate displays dose-dependent anti-seizure efficacy in neonatal rats. Unlike PHB and PHT, it does not induce neurotoxicity in P7 rats. Thus, cenobamate may be effective at treating neonatal seizures while avoiding unwanted neurotoxic side effects such as cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Physiology, Georgetown University, Washington, DC, USA.
- Department of Pharmacology & Physiology, Georgetown University, Washington, DC, USA; Interdisciplinary Program in Neuroscience, Georgetown University, Washington, DC, USA; Department of Neuroscience, Georgetown Universi…
Förderung
- NICHD NIH HHS
- NIGMS NIH HHS
- NICHD
- National Institutes of Health
- NIGMS
Zitieren
APA
Witherspoon, E., Williams, G., Zuczek, N., & Forcelli, P. A. (2024). Cenobamate suppresses seizures without inducing cell death in neonatal rats. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109898
Vancouver
Witherspoon E, Williams G, Zuczek N, Forcelli PA. Cenobamate suppresses seizures without inducing cell death in neonatal rats. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109898
BibTeX
@article{Witherspoon2024,
author = {Witherspoon, Eric and Williams, Gabrielle and Zuczek, Nicholas and Forcelli, Patrick A},
title = {Cenobamate suppresses seizures without inducing cell death in neonatal rats},
journal = {Epilepsy & Behavior},
year = {2024},
doi = {10.1016/j.yebeh.2024.109898}
}
EUVIMED